OUR PRODUCTS

MOBILE APPS

GENERAL INFO

INTS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Intensity Therapeutics (INTS) Earnings Date & Reports

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

INTS is expected to report earnings to fall 9.62% to -11 cents per share on November 18

Intensity Therapeutics INTS Stock Earnings Reports

Q3'25

Est.

$-0.12

Q2'25

Beat

by $0.03

Q1'25

Missed

by $0.04

Q4'24

Missed

by $0.95

Q3'24

Beat

by $0.06

The last earnings report on August 07 showed earnings per share of -12 cents, beating the estimate of -15 cents. With 4.45M shares outstanding, the current market capitalization sits at 13.27M.

View a ticker or compare two or three

Compare

INTS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For INTS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. INTS showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1 Enterprise Drive

Phone

+1 203 221-7381

Employees

Web

https://www.intensitytherapeutics.com